Business & Economy

Major drugmaker loses $27 billion in market value after failed trial

Two companies announced on Thursday that the heart-disease drug they had been developing failed its Phase 3 trial.

Source MarketWatch AI Summary Updated 1h 48m ago

Story intelligence Beta

Freshness Fresh Updated 1h 48m ago

Confidence Checking

Coverage Checking

Views New Be the first to read

Read time 1 min ~18 words

AI Summary

Two companies announced on Thursday that the heart-disease drug they had been developing failed its Phase 3 trial.

Read full article on Marketwatch

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence

SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow